Bone marrow and serum concentrations of 25-hydroxyvitamin D, 24,25-dihydroxyvitamin D, and 1 alpha,25-dihydroxyvitamin D in patients with leukemia and normal subjects.
Bone marrow and serum concentrations of 25-hydroxyvitamin D, 24,25-dihydroxyvitamin D, and 1 alpha,25-dihydroxyvitamin D in patients with leukemia and normal subjects.
复制标题
白血病患者和正常受试者的骨髓和血清中 25-羟基维生素 D、24,25-二羟基维生素 D 和 1 α,25-二羟基维生素 D 的浓度。
DOI:
--
复制
发表时间:
1989
影响因子:
1.6
通讯作者:
S. Yoshida
中科院分区:
文献类型:
--
作者:
S. Masuda;T. Okano;K. Noma;M. Hamasaki;T. Kobayashi;H. Oh;S. Yoshida
Concentrations of 25-hydroxyvitamin D (25-OH-D), 24,25-dihydroxyvitamin D [24,25(OH)2D], and 1 alpha,25-dihydroxyvitamin D [1,25(OH)2D] in bone marrow and serum of patients with leukemia and normal subjects were assayed. There were highly significant correlations between the bone marrow and serum concentrations of the respective vitamin D metabolites. Especially, the concentrations of 25-OH-D and 1,25(OH)2D in the bone marrow gave very similar values to those in serum. This is a big advantage in controlling the bone marrow levels of vitamin D metabolites in patients with leukemia, because doctors can calculate the bone marrow levels from the serum levels of the respective vitamin D metabolites without bone marrow aspiration. When 1 alpha-hydroxyvitamin D3 (1 alpha-OH-D3) was administered orally to eight patients with leukemia, clinical conditions were improved in seven patients: four complete remissions (CR), one partial response (PR), and two minor responses (MR) without severe hypercalcemia. The results suggest that the therapy with 1 alpha-OH-D3 is fairly effective for curing human leukemia although it is not dramatic.
DOI:
--
发表时间:
1985
期刊:
Cancer treatment reports
影响因子:
--
作者:
Koeffler,HP;Hirji,K;Itri,L
通讯作者:
Itri,L